
SIBN Valuation
SI-BONE Inc
- Overview
- Forecast
- Valuation
- Earnings
SIBN Relative Valuation
SIBN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SIBN is overvalued; if below, it's undervalued.
Historical Valuation
SI-BONE Inc (SIBN) is now in the Fair zone, suggesting that its current forward PS ratio of 3.36 is considered Fairly compared with the five-year average of -17.33. The fair price of SI-BONE Inc (SIBN) is between 16.20 to 35.07 according to relative valuation methord.
Relative Value
Fair Zone
16.20-35.07
Current Price:16.22
Fair
-28.57
PE
1Y
3Y
5Y
Trailing
Forward
87.09
EV/EBITDA
SI-BONE Inc. (SIBN) has a current EV/EBITDA of 87.09. The 5-year average EV/EBITDA is 45.83. The thresholds are as follows: Strongly Undervalued below -636.96, Undervalued between -636.96 and -295.57, Fairly Valued between 387.22 and -295.57, Overvalued between 387.22 and 728.62, and Strongly Overvalued above 728.62. The current Forward EV/EBITDA of 87.09 falls within the Historic Trend Line -Fairly Valued range.
-21.83
EV/EBIT
SI-BONE Inc. (SIBN) has a current EV/EBIT of -21.83. The 5-year average EV/EBIT is -14.40. The thresholds are as follows: Strongly Undervalued below -22.90, Undervalued between -22.90 and -18.65, Fairly Valued between -10.15 and -18.65, Overvalued between -10.15 and -5.90, and Strongly Overvalued above -5.90. The current Forward EV/EBIT of -21.83 falls within the Undervalued range.
3.36
PS
SI-BONE Inc. (SIBN) has a current PS of 3.36. The 5-year average PS is 5.76. The thresholds are as follows: Strongly Undervalued below 0.87, Undervalued between 0.87 and 3.31, Fairly Valued between 8.20 and 3.31, Overvalued between 8.20 and 10.64, and Strongly Overvalued above 10.64. The current Forward PS of 3.36 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
SI-BONE Inc. (SIBN) has a current P/OCF of 0.00. The 5-year average P/OCF is -213.55. The thresholds are as follows: Strongly Undervalued below -2029.17, Undervalued between -2029.17 and -1121.36, Fairly Valued between 694.25 and -1121.36, Overvalued between 694.25 and 1602.06, and Strongly Overvalued above 1602.06. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
SI-BONE Inc. (SIBN) has a current P/FCF of 0.00. The 5-year average P/FCF is -6.63. The thresholds are as follows: Strongly Undervalued below -31.21, Undervalued between -31.21 and -18.92, Fairly Valued between 5.66 and -18.92, Overvalued between 5.66 and 17.95, and Strongly Overvalued above 17.95. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
SI-BONE Inc (SIBN) has a current Price-to-Book (P/B) ratio of 4.14. Compared to its 3-year average P/B ratio of 4.83 , the current P/B ratio is approximately -14.33% higher. Relative to its 5-year average P/B ratio of 5.14, the current P/B ratio is about -19.53% higher. SI-BONE Inc (SIBN) has a Forward Free Cash Flow (FCF) yield of approximately -1.80%. Compared to its 3-year average FCF yield of -5.14%, the current FCF yield is approximately -65.00% lower. Relative to its 5-year average FCF yield of -5.40% , the current FCF yield is about -66.66% lower.
4.05
P/B
Median3y
4.83
Median5y
5.14
-1.80
FCF Yield
Median3y
-5.14
Median5y
-5.40
Competitors Valuation Multiple
The average P/S ratio for SIBN's competitors is 3.03, providing a benchmark for relative valuation. SI-BONE Inc Corp (SIBN) exhibits a P/S ratio of 3.36, which is 10.87% above the industry average. Given its robust revenue growth of 21.67%, this premium appears sustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of SIBN decreased by 1.20% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 39.97M to 48.63M.
The secondary factor is the P/E Change, contributed 20.56%to the performance.
Overall, the performance of SIBN in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch

CSTL
Castle Biosciences Inc
21.350
USD
+3.79%

OFIX
Orthofix Medical Inc
14.510
USD
+0.07%

FRSX
Foresight Autonomous Holdings Ltd
2.390
USD
-5.91%

NGL
NGL Energy Partners LP
5.070
USD
-2.31%

MBUU
Malibu Boats Inc
38.290
USD
-1.90%

ORRF
Orrstown Financial Services Inc
34.720
USD
+0.96%

AXL
American Axle & Manufacturing Holdings Inc
5.900
USD
+0.34%

CGNT
Cognyte Software Ltd
8.640
USD
-0.80%

ABL
Abacus Global Management Inc
6.970
USD
+1.01%

NPK
National Presto Industries Inc
106.760
USD
-0.54%
FAQ

Is SI-BONE Inc (SIBN) currently overvalued or undervalued?
SI-BONE Inc (SIBN) is now in the Fair zone, suggesting that its current forward PS ratio of 3.36 is considered Fairly compared with the five-year average of -17.33. The fair price of SI-BONE Inc (SIBN) is between 16.20 to 35.07 according to relative valuation methord.

What is SI-BONE Inc (SIBN) fair value?

How does SIBN's valuation metrics compare to the industry average?

What is the current P/B ratio for SI-BONE Inc (SIBN) as of Aug 27 2025?

What is the current FCF Yield for SI-BONE Inc (SIBN) as of Aug 27 2025?

What is the current Forward P/E ratio for SI-BONE Inc (SIBN) as of Aug 27 2025?
